文献速递艾滋病与性传播感染

资源有限地区HIV RNA监测的经济学分析:差异化监测策略

Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic Analysis.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该研究通过模拟模型评估个体化HIV病毒载量监测频率的成本效益。模型参数化使用个体纵向数据,追踪HIV感染者ART启动后10年,优化监测间隔基于年龄、性别、教育、ART时长、依从性及成本效益阈值。结果显示更短固定监测间隔QALY增加但成本上升;低收入环境自适应策略与固定12个月策略效果相似,中等收入环境自适应策略相比每3个月监测节省204美元但QALY略低。

要点

  • 资源有限地区实施自适应监测策略与简单固定间隔策略效果相似。
  • 更短固定监测间隔增加QALY但成本递增。
  • 自适应监测策略在低收入环境与固定12个月策略效果相当。

核心结论

  • 自适应与固定病毒载量监测策略的益处在资源更充足时增加。
  • 中低收入国家自适应策略与简单固定间隔策略效果相似。

研究设计与样本

  • 使用个体纵向数据参数化的模拟模型。
  • 追踪HIV感染者ART启动后10年。
  • 比较个性化监测策略与每1、3、6、12、24个月固定监测间隔的成本效益。

主要发现

  • 固定监测间隔从24个月到1个月,每患者10年折扣质量调整生命年从6.034增至6.221,标准误0.005 QALY。
  • 平均成本从每年监测的3445美元增至每月监测的5393美元,标准误3.7美元。
  • 低收入环境自适应策略达到6.142平均QALY,成本3524美元;固定12个月策略为6.135 QALY,成本3518美元。
  • 中等收入环境自适应策略相比每3个月监测,每患者QALY减少0.008但节省204美元。

临床怎么用

  • 在资源有限地区,可根据资源可用性选择差异化HIV病毒载量监测策略。
  • 低收入环境下可考虑自适应策略作为固定间隔策略的替代。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND.: Viral load (VL) monitoring for patients receiving antiretroviral therapy (ART) is recommended worldwide. However, the costs of frequent monitoring are a barrier to implementation in resource-limited settings. The extent to which personalized monitoring frequencies may be cost-effective is unknown. METHODS.: We created a simulation model parameterized using person-level longitudinal data to assess the benefits of flexible monitoring frequencies. Our data-driven model tracked human immunodeficiency virus (HIV)-infected individuals for 10 years following ART initiation. We optimized the interval between viral load tests as a function of patients' age, gender, education, duration since ART initiation, adherence behavior, and the cost-effectiveness threshold. We compared the cost-effectiveness of the personalized monitoring strategies to fixed monitoring intervals every 1, 3, 6, 12, and 24 months. RESULTS.: Shorter fixed VL monitoring intervals yielded increasing benefits (6.034 to 6.221 discounted quality-adjusted life-years [QALYs] per patient with monitoring every 24 to 1 month over 10 years, respectively, standard error = 0.005 QALY), at increasing average costs: US$3445 (annual monitoring) to US$5393 (monthly monitoring) per patient, respectively (standard error = US$3.7). The adaptive policy optimized for low-income contexts achieved 6.142 average QALYs at a cost of US$3524, similar to the fixed 12-month policy (6.135 QALYs, US$3518). The adaptive policy optimized for middle-income resource settings yields 0.008 fewer QALYs per person, but saves US$204 compared to monitoring every 3 months. CONCLUSIONS.: The benefits from implementing adaptive vs fixed VL monitoring policies increase with the availability of resources. In low- and middle-income countries, adaptive policies achieve similar outcomes to simpler, fixed-interval policies.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Negoescu DM, Zhang Z, Bucher HC, et al. Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic Analysis. Clin Infect Dis. 2017. PMID: 28329208. doi:10.1093/cid/cix177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。